Market Overview

UPDATE: Morgan Stanley Downgrades Clorox on EPS Risk, Muted Long-Term Growth

Share:
Related CLX
Barclays Hikes Targets On U.S. Cosmetics Companies: What You Should Know
Earnings Recap For February 4
RHS: Let's Go Shopping! (Seeking Alpha)

In a report published Thursday, Morgan Stanley analyst Dara Mohsenian downgraded the rating on The Clorox Co. (NYSE: CLX) from Equal-Weight to Underweight, but named an $83.00 price target.

In the report, Morgan Stanley noted, “We are downgrading CLX to UW. Slowing US consumer spending and heightened competitive pressure create near-term EPS risk that we think is not reflected in valuation, particularly as CLX's LT EPS growth potential is more muted than peers'.”

The Clorox Co. closed on Wednesday at $85.68.

Latest Ratings for CLX

DateFirmActionFromTo
Mar 2016BarclaysMaintainsUnderweight
Feb 2016Sterne AgeeDowngradesBuyNeutral
Feb 2016B. RileyMaintainsNeutral

View More Analyst Ratings for CLX
View the Latest Analyst Ratings

Posted-In: Dara Mohsenian Morgan StanleyAnalyst Color Downgrades Analyst Ratings

 

Related Articles (CLX)

View Comments and Join the Discussion!